Cancer whacked by souped-up immune cells

摘要

Augmented immune cells have made an impressive impact on the survival of people with leukaemia. Thirteen people with a form of the cancer called multiple myeloma were treated with genetically engineered T-cells, and all improved. "The fact we got a response in all 13, you can't get betterthan that," says James Noble, CEO of Adaptimmune in Abingdon, UK, which developed the treatment.